About Hubble Therapeutics
Hubble Therapeutics is a private company based in Hanover, New Hampshire, incorporated in 2020 in Delaware. It has reported $9,807,697 raised in one offering on Form D since October 2024. Its chief executive is Jeff Sabados.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 9, 2024 | Oct 21, 2024 | $9,807,697of $11.1M target | 17 | $576K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hubble Therapeutics's Form D filed Oct 21, 2024.